ABBOTT LABORATORIES (ABL.DE) Stock Fundamental Analysis
Europe - FRA:ABL - US0028241000 - Common Stock
109.3 EUR
-1.2 (-1.09%)
Overall ABL gets a fundamental rating of 6 out of 10. We evaluated ABL against 59 industry peers in the Health Care Equipment & Supplies industry. ABL gets an excellent profitability rating and is at the same time showing great financial health properties. ABL is quite expensive at the moment. It does show a decent growth rate. With these ratings, ABL could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
ABL had positive earnings in the past year.
ABL had a positive operating cash flow in the past year.
In the past 5 years ABL has always been profitable.
In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
ABL's Return On Assets of 16.64% is amongst the best of the industry. ABL outperforms 93.22% of its industry peers.
The Return On Equity of ABL (27.65%) is better than 94.92% of its industry peers.
ABL has a Return On Invested Capital of 9.43%. This is in the better half of the industry: ABL outperforms 76.27% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABL is in line with the industry average of 9.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.64% | ||
| ROE | 27.65% | ||
| ROIC | 9.43% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
ABL has a Profit Margin of 32.43%. This is amongst the best in the industry. ABL outperforms 98.31% of its industry peers.
ABL's Profit Margin has improved in the last couple of years.
The Operating Margin of ABL (17.97%) is better than 77.97% of its industry peers.
In the last couple of years the Operating Margin of ABL has grown nicely.
Looking at the Gross Margin, with a value of 56.33%, ABL is in line with its industry, outperforming 52.54% of the companies in the same industry.
In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.97% | ||
| PM (TTM) | 32.43% | ||
| GM | 56.33% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
ABL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ABL remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ABL has less shares outstanding
Compared to 1 year ago, ABL has an improved debt to assets ratio.
2.2 Solvency
ABL has an Altman-Z score of 5.78. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
ABL has a Altman-Z score of 5.78. This is amongst the best in the industry. ABL outperforms 89.83% of its industry peers.
ABL has a debt to FCF ratio of 1.98. This is a very positive value and a sign of high solvency as it would only need 1.98 years to pay back of all of its debts.
ABL's Debt to FCF ratio of 1.98 is fine compared to the rest of the industry. ABL outperforms 77.97% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that ABL is not too dependend on debt financing.
ABL has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.98 | ||
| Altman-Z | 5.78 |
ROIC/WACC1.14
WACC8.26%
2.3 Liquidity
ABL has a Current Ratio of 1.82. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
ABL has a Current ratio (1.82) which is in line with its industry peers.
A Quick Ratio of 1.30 indicates that ABL should not have too much problems paying its short term obligations.
ABL has a Quick ratio of 1.30. This is in the better half of the industry: ABL outperforms 62.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.3 |
3. Growth
3.1 Past
ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.40%, which is quite good.
Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.59% on average per year.
ABL shows a small growth in Revenue. In the last year, the Revenue has grown by 6.37%.
Measured over the past years, ABL shows a small growth in Revenue. The Revenue has been growing by 5.63% on average per year.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
3.2 Future
ABL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.87% yearly.
The Revenue is expected to grow by 7.13% on average over the next years.
EPS Next Y11.28%
EPS Next 2Y10.75%
EPS Next 3Y10.75%
EPS Next 5Y9.87%
Revenue Next Year6.48%
Revenue Next 2Y7.16%
Revenue Next 3Y7.23%
Revenue Next 5Y7.13%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 25.36 indicates a quite expensive valuation of ABL.
Based on the Price/Earnings ratio, ABL is valued a bit cheaper than the industry average as 67.80% of the companies are valued more expensively.
ABL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
ABL is valuated rather expensively with a Price/Forward Earnings ratio of 22.11.
ABL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.33. ABL is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.36 | ||
| Fwd PE | 22.11 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than the industry average as 64.41% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.53 | ||
| EV/EBITDA | 21 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of ABL may justify a higher PE ratio.
PEG (NY)2.25
PEG (5Y)3.34
EPS Next 2Y10.75%
EPS Next 3Y10.75%
5. Dividend
5.1 Amount
ABL has a Yearly Dividend Yield of 1.85%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.36, ABL pays a bit more dividend than its industry peers.
ABL's Dividend Yield is slightly below the S&P500 average, which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
5.2 History
On average, the dividend of ABL grows each year by 11.40%, which is quite nice.
Dividend Growth(5Y)11.4%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
ABL pays out 28.42% of its income as dividend. This is a sustainable payout ratio.
The dividend of ABL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.42%
EPS Next 2Y10.75%
EPS Next 3Y10.75%
FRA:ABL (10/23/2025, 7:00:00 PM)
109.3
-1.2 (-1.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners80.68%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap190.23B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts78.86
Price Target123.46 (12.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
Yearly Dividend1.9
Dividend Growth(5Y)11.4%
DP28.42%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.08%
Min EPS beat(2)-0.58%
Max EPS beat(2)0.73%
EPS beat(4)1
Avg EPS beat(4)-0.34%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)4
Avg EPS beat(8)0.55%
EPS beat(12)8
Avg EPS beat(12)3.44%
EPS beat(16)12
Avg EPS beat(16)8.67%
Revenue beat(2)0
Avg Revenue beat(2)-0.85%
Min Revenue beat(2)-1.37%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-0.81%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.19%
Revenue beat(8)1
Avg Revenue beat(8)-0.29%
Revenue beat(12)5
Avg Revenue beat(12)0.8%
Revenue beat(16)9
Avg Revenue beat(16)2.75%
PT rev (1m)0.07%
PT rev (3m)-1.54%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)-2.75%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.3%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.36 | ||
| Fwd PE | 22.11 | ||
| P/S | 5.11 | ||
| P/FCF | 32.53 | ||
| P/OCF | 24.39 | ||
| P/B | 4.36 | ||
| P/tB | 10.65 | ||
| EV/EBITDA | 21 |
EPS(TTM)4.31
EY3.94%
EPS(NY)4.94
Fwd EY4.52%
FCF(TTM)3.36
FCFY3.07%
OCF(TTM)4.48
OCFY4.1%
SpS21.38
BVpS25.07
TBVpS10.26
PEG (NY)2.25
PEG (5Y)3.34
Graham Number49.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.64% | ||
| ROE | 27.65% | ||
| ROCE | 10.98% | ||
| ROIC | 9.43% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 19.91% | ||
| OM | 17.97% | ||
| PM (TTM) | 32.43% | ||
| GM | 56.33% | ||
| FCFM | 15.72% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | 1.98 | ||
| Debt/EBITDA | 1.19 | ||
| Cap/Depr | 72.02% | ||
| Cap/Sales | 5.25% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.01% | ||
| Profit Quality | 48.47% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.3 | ||
| Altman-Z | 5.78 |
F-Score7
WACC8.26%
ROIC/WACC1.14
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.28%
EPS Next 2Y10.75%
EPS Next 3Y10.75%
EPS Next 5Y9.87%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.48%
Revenue Next 2Y7.16%
Revenue Next 3Y7.23%
Revenue Next 5Y7.13%
EBIT growth 1Y14.57%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.77%
EBIT Next 3Y15.64%
EBIT Next 5Y12.28%
FCF growth 1Y23.45%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y21.27%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%